Skip to main content
Clinical Trials/NCT06260930
NCT06260930
Completed
Not Applicable

Role od Chest Ultrasonography in Interstitial Lung Diseases

Aswan University0 sites80 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interstitial Lung Disease
Sponsor
Aswan University
Enrollment
80
Primary Endpoint
Sensitivity and specificity of the lung sonography for interstitial lung disease screening
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The main aim of this study is to detect the value of transthoracic ultrasonography in the diagnosis and assessment of ILDs in correlation to chest X- ray, blood gases, pulmonary function test and echocardiography and to compare it with high resolution CT (HRCT) as a golden diagnostic investigation.

Detailed Description

Interstitial lung disease (ILD) refers to a group of disorders that are characterized by varying combinations of inflammation and fibrosis involving the space between the epithelial and endothelial basement membranes.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
December 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shazly Ahmed

Associate professor

Aswan University

Eligibility Criteria

Inclusion Criteria

  • Adults (≥18 years) diagnosed with ILD
  • All patients must fulfil the 2018 criteria for HRCT chest finding for the diagnosis of Usual interstitial pneumonia (UIP) form

Exclusion Criteria

  • Patients with cardiac diseases (Left-sided Heart failure, pulmonary edema) \[they may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings\].
  • Patients with chronic kidney diseases (as patients presented with nephrogenic pulmonary edema may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings).

Outcomes

Primary Outcomes

Sensitivity and specificity of the lung sonography for interstitial lung disease screening

Time Frame: 12 months

To estimate the sensitivity and specificity of the lung sonography for interstitial disease screening in comparison with HRCT. \[Time Frame: 12 months\]

Similar Trials